Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bernice Nounamo"'
Autor:
Steven J Conrad, Tahseen Raza, Erich A Peterson, Jason Liem, Richard Connor, Bernice Nounamo, Martin Cannon, Jia Liu
Publikováno v:
PLoS Pathogens, Vol 18, Iss 9, p e1010316 (2022)
The evolutionarily successful poxviruses possess effective and diverse strategies to circumvent or overcome host defense mechanisms. Poxviruses encode many immunoregulatory proteins to evade host immunity to establish a productive infection and have
Externí odkaz:
https://doaj.org/article/aeb4fe02497b47818c7d1537834555c9
Publikováno v:
Molecular Therapy: Oncolytics, Vol 6, Iss C, Pp 90-99 (2017)
A therapeutic approach to improve treatment outcome of ovarian cancer (OC) in patients is urgently needed. Myxoma virus (MYXV) is a candidate oncolytic virus that infects to eliminate OC cells. We found that in vitro MYXV treatment enhances cisplatin
Externí odkaz:
https://doaj.org/article/ab6fb02875c44f618cf67acb4cafe1a5
Autor:
Wei Li, Nathan C. Twaddle, Beverly Spray, Bernice Nounamo, Behjatolah Monzavi-Karbassi, Reza Hakkak
Publikováno v:
Journal of Medicinal Food.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9c102c7f954251c2a2cbaae8688a0e0
https://doi.org/10.1089/jmf.2022.0100
https://doi.org/10.1089/jmf.2022.0100
Autor:
Bernice Nounamo, Fariba Jousheghany, Eric Robb Siegel, Steven R. Post, Thomas Kelly, Soldano Ferrone, Thomas Kieber-Emmons, Behjatolah Monzavi-Karbassi
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 3
Pages: 2506
Volume 24
Issue 3
Pages: 2506
The anti-CSPG4 monoclonal antibodies (mAbs) have shown anti-tumor activity and therapeutic potential for treating breast cancer. In addition, CSPG4 is a dominant tumor-associated antigen that is also involved in normal-tissue development in humans. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b11184112c8b07cf99011caf998404
https://doi.org/10.3390/ijms24032506
https://doi.org/10.3390/ijms24032506
Publikováno v:
Current Developments in Nutrition. 6:306
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::286953f3417a0d574351cefbb60ad30f
https://doi.org/10.1093/cdn/nzac053.047
https://doi.org/10.1093/cdn/nzac053.047
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 6, Iss C, Pp 90-99 (2017)
Molecular Therapy: Oncolytics, Vol 6, Iss C, Pp 90-99 (2017)
A therapeutic approach to improve treatment outcome of ovarian cancer (OC) in patients is urgently needed. Myxoma virus (MYXV) is a candidate oncolytic virus that infects to eliminate OC cells. We found that in vitro MYXV treatment enhances cisplatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8031db3b6506da393e7d736377f6fa5
http://europepmc.org/articles/PMC5573804
http://europepmc.org/articles/PMC5573804
Publikováno v:
Clinical Cancer Research. 25:TMIM-077
Myxoma virus (MYXV) is a poxvirus with oncolytic and immunotherapeutic potential in many cancer models, including ovarian cancer (OC). Moreover, MYXV synergizes with chemotherapy including cisplatin for OC treatment. In this study, we used a p53-/- I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f18481655c42c848b43a4454c777750
https://doi.org/10.1158/1557-3265.ovcasymp18-tmim-077
https://doi.org/10.1158/1557-3265.ovcasymp18-tmim-077
Publikováno v:
Virology
In humans, deleterious mutations in the sterile α motif domain protein 9 (SAMD9) gene are associated with cancer, inflammation, weakening of the immune response, and developmental arrest. However, the biological function of SAMD9 and its sequence-st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a327bd4d01cdd938744c5bb95f1d1bef
https://pubmed.ncbi.nlm.nih.gov/28157624
https://pubmed.ncbi.nlm.nih.gov/28157624